Karyn Lister
About Karyn Lister
Karyn Lister is a Clinical Development Manager at Starpharma, with extensive experience in clinical research and project management across various therapeutic areas. She previously held multiple roles at GSK, contributing to her expertise in Good Clinical Practice and medical writing.
Current Role at Starpharma
Karyn Lister serves as the Clinical Development Manager at Starpharma, a position she has held since 2020. In this role, she is responsible for overseeing clinical development activities, ensuring compliance with regulatory standards, and managing clinical trials. Her work is based in Abbotsford, Victoria, Australia, where she applies her extensive experience in clinical research to advance the company's projects.
Previous Experience at GSK
Karyn Lister has a significant history with GSK, where she held multiple roles over a span of several years. She worked as a Local Study Manager from 2017 to 2020, and as a Principal Clinical Research Scientist from 2016 to 2020. Her earlier positions included Senior Clinical Research Associate and Clinical Scientist in Specialty Brands, among others. This diverse experience has equipped her with comprehensive knowledge of clinical trial processes and project management.
Education and Expertise
Karyn Lister holds a Doctor of Philosophy (Ph.D.) in Immunology from Monash University, which she completed from 2003 to 2006. She also earned a Bachelor's Degree in Science from the University of Melbourne between 1998 and 2000. Additionally, she completed The Medicines Australia Code of Conduct - Program 1 at The University of Tasmania in 2015. Her educational background supports her expertise in Good Clinical Practice (GCP) and project management of clinical trials.
Therapeutic Knowledge and Skills
Karyn Lister possesses diverse therapeutic knowledge across several medical fields, including respiratory medicine, oncology, HIV, renal medicine, and first-in-human studies with healthy volunteers. She has developed strong skills in medical writing and reporting, which are essential for documenting clinical trial results and regulatory submissions. Her comprehensive skill set enhances her contributions to clinical development initiatives.